Skip to main content
SINGULAR HEALTH GROUP LTD logo

SINGULAR HEALTH GROUP LTD — Investor Relations & Filings

Ticker · SHG ISIN · AU0000129892 ASX Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 364 across all filing types
Latest filing 2022-07-04 Transaction in Own Shar…
Country AU Australia
Listing ASX SHG

About SINGULAR HEALTH GROUP LTD

https://singular.health/

Singular Health Group Ltd specializes in the development and commercialization of medical imaging software designed to enhance personalized healthcare. The company’s primary offering, the 3Dicom software suite, employs proprietary volume rendering technology to transform standard 2D DICOM files, such as CT and MRI scans, into immersive 3D visualizations. This platform supports surgical planning, remote clinical collaboration, and patient education by providing interactive anatomical models. Singular Health integrates artificial intelligence to automate image segmentation and diagnostic workflows, facilitating more precise clinical outcomes. Through its 'Scan to Surgery' initiative, the company bridges the gap between diagnostic imaging and physical intervention using virtual reality and 3D printing. Its solutions target medical practitioners, dental professionals, and healthcare institutions globally.

Recent filings

Filing Released Lang Actions
Notification of cessation of securities - SHG 4 pages 24.4KB
Transaction in Own Shares Classification · 95% confidence The document is a notification about the cessation of certain securities (options) by Singular Health Group Ltd, detailing the number of securities that have ceased, the reason for cessation, and the updated issued capital following these changes. It is an announcement related to changes in the company's issued capital but does not describe a new share issue or capital increase. Instead, it reports the lapse of conditional rights to securities. This fits best under the category of Transaction in Own Shares (POS), which covers reports of the company buying back or selling its own shares or changes in securities holdings such as lapses or cessations. The document is short (4021 characters) and is a formal announcement of a securities cessation event, not a full financial report or regulatory filing. Therefore, the most appropriate classification is POS with high confidence.
2022-07-04 English
Restricted Securities to be Released from Escrow 1
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 19 May 2022 from Singular Health Group Ltd regarding the release of restricted securities from escrow. It mentions Listing Rule 3.10A and specifies the number of shares to be released from escrow on a future date. The content is a brief regulatory announcement about share release, not a financial report, management discussion, or detailed filing. The document length is short (724 characters), and it is an announcement of a capital-related event (release of shares from escrow). This fits best under Capital/Financing Update (CAP) as it relates to changes in capital structure or share status.
2022-05-18 English
Quarterly Activities/Appendix 4C Cash Flow Report 13 pages 1.1MB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 26 April 2022 titled 'ACTIVITIES REPORT FOR THE QUARTER – 31 MARCH 2022'. It provides a detailed update on the company's operations, financial position, and activities during the quarter ending 31 March 2022. It includes financial figures such as operating expenditure, cash inflows, and government grants, as well as operational milestones and strategic updates. The document is approximately 15,000 characters long, indicating it is a substantive report rather than a brief announcement. The content aligns with a quarterly report providing comprehensive financial and operational information for a period shorter than a full fiscal year. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q3 2022
2022-04-25 English
AE Commissions Medical Manufacturing Facility 4 pages 514.7KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement from Singular Health Group Ltd dated 16 March 2022. It details the commissioning of a medical manufacturing facility by Additive Engineering, a company in which Singular Health holds a 25% stake. The announcement describes operational milestones, partnerships, and business developments related to the facility and its 3D printing capabilities. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is a corporate update on operational progress and strategic partnerships rather than a financial report or regulatory filing. It is not a report publication announcement since it contains substantive information about the commissioning and business activities. The content fits best under a general regulatory announcement category for corporate developments and operational updates. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2022-03-15 English
China-based JV Formed and 3Dicom trial at Macau Hospital 3 pages 1.5MB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 24 February 2022 from Singular Health Group Ltd. It details the formation of a China-based joint venture (JV) and a software trial at a Macau hospital. The content focuses on business development, strategic partnerships, and market expansion plans rather than financial results, regulatory filings, or management changes. There are no financial statements, voting results, or executive compensation details. The document is a corporate announcement about a JV and product trial, which fits best under Capital/Financing Update (CAP) as it involves funding commitments and strategic investment activities related to the JV formation.
2022-02-23 English
Half Year Accounts 23 pages 1.3MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Appendix 4D for the Half-Year Ended 31 December 2021' and includes detailed financial statements such as the Consolidated Statement of Profit or Loss and Other Comprehensive Income, Statement of Financial Position, and Notes to the Financial Statements. It also contains a Directors' Report, Auditor's Independence Declaration, and an Independent Auditor's Review Report. The content covers a half-year period and provides comprehensive financial data and management discussion. This matches the characteristics of an Interim / Quarterly Report (IR), which is a comprehensive financial report for a period shorter than a full fiscal year and includes substantive financial data and analysis. The document is not merely an announcement or a certification but contains the full interim financial report itself. H1 2022
2022-02-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.